ResMed Inc (RMD)
183.78
-0.44
(-0.24%)
USD |
NYSE |
Apr 24, 16:00
183.82
+0.04
(+0.02%)
Pre-Market: 20:00
ResMed Cash from Financing (TTM): -858.24M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -858.24M |
| September 30, 2023 | 313.62M |
| June 30, 2023 | 422.87M |
| March 31, 2023 | 668.96M |
| December 31, 2022 | 887.66M |
| September 30, 2022 | -263.21M |
| June 30, 2022 | -128.36M |
| March 31, 2022 | -299.90M |
| December 31, 2021 | -397.58M |
| September 30, 2021 | -496.40M |
| June 30, 2021 | -764.63M |
| March 31, 2021 | -886.96M |
| December 31, 2020 | -710.03M |
| September 30, 2020 | -392.47M |
| June 30, 2020 | -317.29M |
| March 31, 2020 | -178.49M |
| December 31, 2019 | -113.70M |
| September 30, 2019 | 335.74M |
| June 30, 2019 | 580.64M |
| March 31, 2019 | 89.55M |
| December 31, 2018 | -270.15M |
| September 30, 2018 | -775.79M |
| June 30, 2018 | -1.027B |
| March 31, 2018 | -559.92M |
| December 31, 2017 | -336.32M |
| Date | Value |
|---|---|
| September 30, 2017 | -328.90M |
| June 30, 2017 | -262.87M |
| March 31, 2017 | 567.08M |
| December 31, 2016 | 603.86M |
| September 30, 2016 | 468.13M |
| June 30, 2016 | 612.58M |
| March 31, 2016 | -332.03M |
| December 31, 2015 | -341.93M |
| September 30, 2015 | -147.42M |
| June 30, 2015 | -255.79M |
| March 31, 2015 | -159.46M |
| December 31, 2014 | -277.86M |
| September 30, 2014 | -311.24M |
| June 30, 2014 | -297.32M |
| March 31, 2014 | -273.55M |
| December 31, 2013 | -159.56M |
| September 30, 2013 | -151.66M |
| June 30, 2013 | -153.93M |
| March 31, 2013 | -84.34M |
| December 31, 2012 | -89.88M |
| September 30, 2012 | -85.47M |
| June 30, 2012 | -177.10M |
| March 31, 2012 | -149.77M |
| December 31, 2011 | -135.14M |
| September 30, 2011 | -126.80M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-886.96M
Minimum
Mar 2021
887.66M
Maximum
Dec 2022
-136.72M
Average
-263.21M
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
| Stryker Corp | -1.594B |
| Boston Scientific Corp | 5.00M |
| Integer Holdings Corp | -18.01M |
| Haemonetics Corp | 100.06M |
| Insulet Corp | -13.60M |